Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 20 studies | 26% ± 12% | |
| plasma cell | 18 studies | 41% ± 14% | |
| naive B cell | 9 studies | 25% ± 10% | |
| IgA plasma cell | 6 studies | 27% ± 11% | |
| IgG plasma cell | 6 studies | 30% ± 10% | |
| memory B cell | 5 studies | 23% ± 7% | |
| plasmablast | 5 studies | 27% ± 15% | |
| immature B cell | 4 studies | 31% ± 13% |
Insufficient scRNA-seq data for expression of FCRL5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 88% | 415.42 | 509 / 578 | 70% | 3.63 | 810 / 1155 |
| stomach | 65% | 354.90 | 233 / 359 | 44% | 2.02 | 125 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 47.61 | 29 / 29 |
| spleen | 100% | 10494.41 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 3796.56 | 883 / 929 | 0% | 0 | 0 / 0 |
| intestine | 55% | 1387.88 | 528 / 966 | 33% | 1.13 | 174 / 527 |
| breast | 34% | 145.22 | 157 / 459 | 31% | 1.09 | 344 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 64% | 3.34 | 29 / 45 |
| bladder | 33% | 165.19 | 7 / 21 | 30% | 1.33 | 152 / 504 |
| esophagus | 19% | 67.12 | 276 / 1445 | 33% | 1.29 | 61 / 183 |
| kidney | 40% | 220.10 | 36 / 89 | 11% | 0.42 | 101 / 901 |
| thymus | 28% | 380.71 | 185 / 653 | 22% | 0.93 | 132 / 605 |
| liver | 43% | 86.81 | 98 / 226 | 7% | 0.21 | 27 / 406 |
| pancreas | 3% | 5.90 | 11 / 328 | 37% | 1.25 | 66 / 178 |
| uterus | 14% | 28.21 | 24 / 170 | 26% | 0.66 | 118 / 459 |
| skin | 1% | 1.81 | 15 / 1809 | 36% | 1.72 | 169 / 472 |
| prostate | 25% | 104.36 | 61 / 245 | 4% | 0.10 | 19 / 502 |
| ovary | 14% | 24.14 | 25 / 180 | 12% | 0.27 | 51 / 430 |
| adipose | 16% | 70.61 | 188 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 11% | 69.12 | 152 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 7% | 15.41 | 18 / 258 | 1% | 0.02 | 2 / 230 |
| heart | 4% | 11.32 | 37 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.11 | 3 / 80 |
| brain | 0% | 0.53 | 8 / 2642 | 1% | 0.11 | 5 / 705 |
| muscle | 0% | 0.13 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006955 | Biological process | immune response |
| GO_0007338 | Biological process | single fertilization |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0009986 | Cellular component | cell surface |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0043235 | Cellular component | receptor complex |
| GO_0004888 | Molecular function | transmembrane signaling receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FCRL5 |
| Protein name | Fc receptor-like protein 5 (FcR-like protein 5) (FcRL5) (BXMAS1) (Fc receptor homolog 5) (FcRH5) (Immune receptor translocation-associated protein 2) (CD antigen CD307e) |
| Synonyms | UNQ503/PRO820 FCRH5 IRTA2 |
| Description | FUNCTION: May be involved in B-cell development and differentiation in peripheral lymphoid organs and may be useful markers of B-cell stages. May have an immunoregulatory role in marginal zone B-cells. May play a role in fertilization (By similarity). . |
| Accessions | ENST00000368189.3 [Q96RD9-4] ENST00000368190.7 [Q96RD9-3] Q96RD9 ENST00000361835.8 [Q96RD9-1] |
